Andrus: The biggest risk is fragmented, disconnected data collection across sites. If you think about a large phase 3 trial ...
In today’s ACT Brief, we examine how protocol-driven eSource is reshaping data capture at sites, how digital protocols and ...
As clinical development grows more complex, sponsors are rethinking how outsourcing models, technology, and partnerships align to support both speed and sustainability. The shift toward hybrid models, ...
Steve Rosenberg, CEO of uMotif, explores the core challenges of clinical trial recruitment and retention, and discusses how digital tools empower sites and patients to build more effective, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results